Genentech, Inc. (DNA)

NetscribeBiotech (76.22) Submitted: 2/02/07 4:23 AM : Start Price: $87.24 DNA Score: 1.42

Genentech, a pronounced biotechnology company which has been making it a habit of beating street consensus, is involved in the discovery, development and marketing of various drugs for the treatment of cancer, allergic asthma, plaque psoriasis, hormo...

Report this Post Replies: 2 | Reply | Permalink

Mojo007 (59.78) Submitted: 2/24/08 8:42 PM : Start Price: $78.12 DNA Score: 5.88

Genentech is a great biotech company in terms of growth and demand for existing products. To my surprise, Avasin was just approved by the FDA for breast cancer treatment. With over half of eligible lung cancer patients already taking this drug, and...

Report this Post Replies: 0 | Reply | Permalink

bbobNJ (61.79) Submitted: 8/25/06 4:41 AM : Start Price: $79.70 DNA Score: -0.42

Genentech has been moving sideways for a year, and it may do the same throughout 2007, but at the rate earnings are increasing this stock will eventually rise. The science at Genentech is very very well funded and will continue to lead the industry...

Report this Post Replies: 0 | Reply | Permalink

Sandman333 (30.71) Submitted: 1/24/07 12:16 PM : Start Price: $89.40 DNA Score: -1.76

I can personally attest to the effectiveness of Avastin. I do not have cancer, but rather an as-yet unexplained condition that is causing the blood vessels in my eye to grow abnormally. This causes vision distortion and loss. My condition may be c...

Report this Post Replies: 0 | Reply | Permalink

rodik (< 20) Submitted: 6/22/07 3:56 PM : Start Price: $74.87 DNA Score: 19.36

The best run biotechnology company and the best growing in the whole sector. A fair valuation is $120, while the stock is selling at around $76, coming down slowly from its high $100. We buy to possibly double our money in a year time.

Report this Post Replies: 1 | Reply | Permalink

spikenailz (75.27) Submitted: 7/26/07 1:08 PM : Start Price: $76.68 DNA Score: 15.85

DNA is on the cheap right now so you better buy it before it gets hot. This company has and always will be the leader in biotech R&D. I can't believe how undervalued his stock is right now.

Report this Post Replies: 0 | Reply | Permalink

xthecritic (93.47) Submitted: 2/07/08 1:36 PM : Start Price: $71.33 DNA Score: 15.76

Genentech is the #1 biotech company in the world. The company is currently trading near its 52 week low and at a 25x PE multiple with a strong growth profile. This is a great opportunity to get into DNA at a nice valuation. Healthcare companies wi...

Report this Post Replies: 0 | Reply | Permalink

Sanjiv523 (< 20) Submitted: 8/18/06 2:49 AM : Start Price: $82.30 DNA Score: 3.04

This company is waaaaayyy overvalued. They have a decent pipeline. However, it is certainly not that great for a drug company, which is basically their peer group at this point. It's OK to give a biotech a high P/E when they have small profits becaus...

Report this Post Replies: 0 | Reply | Permalink

gameguru (< 20) Submitted: 9/13/06 4:52 PM : Start Price: $77.94 DNA Score: 3.52

Genentech is a premier biotech that is on its way to major pharmaceutical status. With one of the most promising oncology treatments available (Avastin), it will have profits with which to drive further research and development for a long time to co...

Report this Post Replies: 0 | Reply | Permalink

SBeren (36.94) Submitted: 12/11/07 10:16 AM : Start Price: $68.65 DNA Score: 29.41

Here's why Genentech will bounce back with no problems:

1) The Avastin vote was only 5-4 against.
2) Avastin has already been approved by the FDA for treating lung and colon cancer.
3) Physicians prescribe Avastin "off-label" for breast cancer anywa...

Report this Post Replies: 0 | Reply | Permalink